Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 346 participants.
Also called NCT02502110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 346 participants
- Registry
-
NCT02502110
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02502110. Randomized; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2019-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Drug)
- rosuvastatin
- Lead sponsor
- The Third Xiangya Hospital of Central South University
Record details
- Record id
cardio:ct-nct02502110- Content hash
9415e0f9c1c6c5a5b09b219ab1f9514283339883cb74d73ae57512fea27a4489